Noevir Holdings Co (TSE:4928) Net Income: 円8,107 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4928 Noevir Holdings Co Ltd TSE:4928
75 GF Score
Price 円4,810.00
GF Value 円4,981.95
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Noevir Holdings Co Net Income?

Noevir Holdings Co TSE:4928 +1.48% 75 Net Income is 円8,107 Mil as of Mar. 2026. GuruFocus rates TSE:4928 with a GF Score™ of 75/100 and a GF Value™ of 円4,981.95 (Fairly Valued). The stock has 3 warning signs investors should review.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Noevir Holdings Co's Net Income for the three months ended in Mar. 2026 was 円1,397 Mil. Its Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 円8,107 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Noevir Holdings Co's Earnings per Share (Diluted) for the three months ended in Mar. 2026 was 円40.90.


Noevir Holdings Co  (TSE:4928) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Noevir Holdings Co's Earnings per Share (Diluted) (EPS) for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Noevir Holdings Co Net Income Related Terms


Noevir Holdings Co Net Income Historical Data

* Premium members only.

The historical data trend for Noevir Holdings Co's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noevir Holdings Co Net Income Chart

Noevir Holdings Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,383.00 7,589.00 7,673.00 7,970.00 8,030.00

Noevir Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,668.00 1,482.00 3,907.00 1,321.00 1,397.00
TSE:4928
75GF Score
Noevir Holdings Co Ltd TSE:4928
Net Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Noevir Holdings Co Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Noevir Holdings Co's Net Income for the fiscal year that ended in Sep. 2025 is calculated as

Net Income(A: Sep. 2025 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=11879+-3690+0+-159
=8,030

Noevir Holdings Co's Net Income for the quarter that ended in Mar. 2026 is calculated as

Net Income(Q: Mar. 2026 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=2372+-923+0+-52
=1,397

Net Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8,107 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Income →
What does a Net Income of 円8,107 Mil mean?
Noevir Holdings Co (TSE:4928) has a Net Income of 円8,107 Mil as of Mar. 2026. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Noevir Holdings Co and its competitors.
Is Noevir Holdings Co's Net Income too high?
Noevir Holdings Co's current Net Income is 円8,107 Mil. Overall, Noevir Holdings Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's Net Income compare to PG and CL?
Noevir Holdings Co's Net Income of 円8,107 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Consumer Packaged Goods company?
A good Net Income depends on the Consumer Packaged Goods industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Noevir Holdings Co and its competitors. Noevir Holdings Co's current Net Income is 円8,107 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Fairly Valued. The stock's GF Value™ is 円4,981.95, compared to a current price of 円4,810.00 — trading 3.5% below its estimated fair value. The current Net Income is 円8,107 Mil. Noevir Holdings Co's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current Net Income is 円8,107 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?

Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued. The current stock price of 円4,810.00 is trading 3.5% below its estimated GF Value™ of 円4,981.95. GuruFocus considers Noevir Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4928:

  • Net Income: 円8,107 Mil
  • GF Value™: 円4,981.95 vs. price of 円4,810.00 (3.5% below fair value)
  • GF Score™: 75/100 with 3 warning signs

No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Noevir Holdings Co Business Description

Address 13-1, Minatojima Nakamachi 6-chome, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
75GF Score

Get the complete analysis for TSE:4928

Net Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,810.00
Price
円4,981.95
GF Value